By decreasing m6A levels of ADAM19 and increasing its expression in glioblastoma stem cells (GSCs), downregulation of METTL3/14 stimulates the proliferation and self-renewal of GSCs, ultimately resulting in GBM [87]. Here, ADAM19 is linked to glioblastoma.